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ABSTRACT: EUGENOL a widely used pharmaceutical agent proceeds toxicity on inhalation in 
rats.  Two different doses 20 & 30 µg/100g body weight/ day of eugenol were given 
intramuscularly to male albino rats for 10 days and the liver function was assessed by measuring 
the specific enzyme activities, and total and differential bilirubin concentration.  There was an 
appreciable increase in total as well as differential bilirubin fractions and a dose dependent 
increase was noticed in the activities of alkaline phosphatase, transminases, lactate 
dehyrogenase with a decrease in the activity of glytamyl transferase activity, and suggesting 
eugenol to have a toxic effect on liver. 
 
INTRODUCTION 
 
Plant principles used for medicinal purposes 
should be administrated in proper 
concentration so as to avoid any toxicity due 
to their accumulation.  Sometimes, even the 
therapeutic doses given for a particular 
ailment may be toxic to other systems.   
Therefore, the study of any plant principle 
on various systems is mandatory. 
 
Eugenol, a phenolic compound is a major 
constituent of the essential oil extracted 
from cloves (Eugenia aromatica) and can be 
synthesized from anethold.  Nutmeg 
(Myristica fragrans)  and betelvine  (Piper 
betle L) are also good sources of eugenol
1.  
It is an ingredient of dentifrices, gargles, 
chewing gums and also used for scenting 
soaps and toilet waters in perfumery.  This 
oil is employed as a local analgestic for 
hypertensive dentistries and carious 
cavities
2, externally used as a rubefacient 
and counterirrigant, and internally as a 
carminative and antispasmodie agent
3.  The 
antipyretic activity of eugenol has been 
demonstrated in rabbits
4.   
 
 Eugenol being very widely used in dentistry 
in  a Zincoxide-eugenol combination and 
also as an antibiotic motivated the toxicity 
study of this compound on liver tissue, the 
sole organ responsible for the detoxification 
of drugs. 
 
MATERIALS AND METHODS 
 
Adult male albino rats of wistar strain 
weighing about 200 – 250 gm body weight 
were maintained under uniform laboratory 
conditions and were provided with standard 
rat pellet diet (M/s. Hindustan Lever Ltd., 
Bangalore) and water ad libitum.  They were 
divided into 3 groups, each comprising of 5 
animals.  Animals in Group I received 1% 
Sodium hydroxide solution and served as 
controls.  Group II and Group III received 
eugenol of 20 µg and 30 µg respectively per Pages 213 - 217 
100 gm. Body weight per day 
intramuscularly for 10 days. 
 
24 Hours after the last injection, the animals 
were sacrificed by decapitation.  The liver 
was removed and cleaned in 0.9% saline.   
Required amount of tissue was homogenized 
and centrifuged in appropriate media and 
speed respectively and the supernatant was 
used for the estimation of total protein
5, 
alkaline phosphatase
6, aspirate and alanine 
transaminases
7, lactate dehydrogenase
8, Y 
Glutamyl transferase
9, estimation of total 
and conjugated bilirubin
10.  The data were 
analysed statistically, using students‘t’ used. 
 
RESULTS AND DISCUSSION 
 
Table: 1 depicts the effect of eugenol at two 
different doses on total protein 
concentration, bilirubin levels and a few 
enzymes in liver.  Eugenol administration in 
both the doses caused a significant decrease 
in total protein concentration.  The total as 
well  as the conjugated and un-conjugated 
bilirubin levels showed a significant 
increase with the high dose treatment.   
However, the low dose group did not show 
any significant change.  On treating the 
animals with a low and high dose of 
eugenol, there was significant increase 
observed in the alkaline phosphatase, 
alanine and asparatate transminases and 
lactate dehydrogenase in the liver tissue 
when compared with the control but the r-
glutamyl transferase showed a significant 
decrease. 
 
Liver is the vital organ concerned with the 
drug metabolism.  It is essential to study the 
effect of any pharmaceutical agent on these 
organs, if it is intended to be used for human 
welfare in any form.  This is important 
because liver damages, if any, will alter the 
physiology and structure of the vital organs 
and have a serious effect on the overall 
metabolism.  Clark
11  found eugenol to 
produce temporary distress like irregular 
breathing, weight loss and reduced food and 
water intake.  The observed decrease in liver 
protein concentration in the present study 
substantiates this report.  As liver is the 
chief organ of protein synthesis, even mild 
lesions in this organ may alter its normal 
function. 
 
After production in the peripheral tissues, 
bilirubin is transported to the liver in the 
association with albumin
12.  Inside the 
hepatocytes, bilirubin is rapidly conjugated 
with glucuronic acid to produced bilirubin 
monoglucuronide and bilirubin 
diglucuronide, which are then exerted in 
bile
13.  There may be a reduction in the 
number of functioning liver cells as in 
chronic hepatitis, so that all liver functions 
are impaired.  Conditions such as infective 
or toxic jaundice in which there is extensive 
damage to liver cells, but also a considerable 
degree of intrahepatic obstruction resulting 
in appreciable decrease in the exertion of 
conjugated bilirubin
14.  The present study 
with administration of eugenol reveals that 
the liver function is affected which is 
supported by the observation made by an 
appreciable increase in the total bilirubin 
and conjugated bilirubin fraction suggesting 
liver toxicity. 
 
Serum alkaline phosphatase measurements 
are of particular interest in the investigation 
of two groups of conditions:   Hepatobiliary 
disease and bone disease associated with 
osteoblastic activity.  Recent studies suggest 
that the response of liver to any form of 
biliary tree obstruction is to synthesize more 
alkaline phosphatase, i.e., the effect is one 
the enzyme induction.  The main site of new 
enzyme synthesis is the hepatocyctes 
adjacent to the biliary canaliculi.  Some of 
the newly formed enzymes enter  the 
circulation to raise the enzyme level in Pages 213 - 217 
serum.  The elevation tends to be more 
marked (more than 3 fold) in extrahepatic 
obstruction than in intrahepatic obstruction 
and is greater, the more complete is the 
obstruction.  Intrahepatic obstruction of bile 
flow by drugs such as chlorpromazine that 
affect the biliary tree also raised alkaline 
phosphatase, but usually to lesser extent.  In 
the present study, the treatment of eugenol 
led to a dose  dependent increase in ALP 
activity, probably suggesting an intrahepatic 
obstruction.  In infectious hepatitis and other 
inflammatory conditions affecting the liver, 
alkaline transaminase is characteristically as 
high as or  higher than aspirate 
transaminase
15.  Slight or moderate 
elevations of both transminase activities 
may be observed after intake of alchol, in 
delirium tremens and after administration of 
a variety of drugs, such as opiates, 
salicylates or ampicillin
16.  Although serum 
levels of both alanine and aspirate 
transminases become elevated whenever 
disease processes, affect liver cell integrity, 
alanine transminase is the more liver 
specific enzyme
17. 
 
Lactate dehydrogenase activity may be 
elevated in almost all causes of hemolysis 
and liver disease but not as great as the 
increase seen in amino-transferase activity
18.  
Administration of eugenol induced in 
increase in transaminase and dehydrogenase 
levels in liver supports the hepatotoxicity of 
the drug as shown by Manake
19. 
 
All forms of liver disease lead to an increase 
in membrane bound gamma glutamyl 
transferase (r-GGT) in serum.  This 
elevation of serum activity may be due to a 
release of cell membrane fragments into the 
circulation, a process that may be a result of 
membrane fragmentation by bile acids, 
particularly in cholestatic disease, the stasis 
and prolonged contact of bile acids (which 
are detergents) with canlicular and bile duct 
epithelia could solubilzie and release r-
glutamyl transferase20.  The observed 
decrease in r-GGT activity in liver may be 
due to loss of liver cell membrane fragments 
into the circulation. 
 
Thus, it is evident that eugenol 
administration exerts as adverse effect on 
the liver as indicated by the responses of the 
biochemical parameters studied. Pages 213 - 217 
 
EFFECT OF EUGENOL ON LIVER OF ADULT RATS 
 
PARAMETER  CONTROL  LOW DOSE   HIGH DOSE 
Protein 
(mg/g wet tissue) 
 
Total Bilirubin 
 
Conjugated Bilirubin 
 
Unconjugated Bilirubin 
(mg/g Wet tissue) 
 
Alkaline Phosphatase 
 
Alanine Transaminase 
 
Asparate Transaminase 
 
Lactate dehydrogenase 
 
r-glutamyl transferase 
 
98.54 ± 11.0 
 
 
20.05 ± 1.06 
 
2.50 ± 0.02 
 
17.34 ± 0.75 
 
 
0.41 ± 0.06 
 
1.72 ± 0.21 
 
1.23 ± 0.02 
 
1.65 ± 0.01 
 
0.56 ± 0.02 
95.32 ± 9.51 
 
 
18.93 ± 2.12 
 
1.95 ± 0.01* 
 
16.51 ± 0.68* 
 
 
0.50 ± 0.03* 
 
2.11  ± 0.14* 
 
1.91 ± 0.01* 
 
2.15 ± 0.05* 
 
0.42 ± 0.01* 
79.12 ± 4.7* 
 
 
24.89 ± 2.13* 
 
5.46 ± 1.01* 
 
19.23 ± 1.81* 
 
 
0.70 ± 0.01* 
 
3.43 ± 0.09* 
 
2.36 ± 0.02* 
 
2.93 ± 0.02* 
 
0.37 ± 0.01* 
 
 
VALUES ARE EXPRESSED AS MEAN ± S.D. OF 6 SAMPLES 
STATISTICAL SIGNIFICANCE AT P < 0.05 IS REPRESENTED BY A* 
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